35th Congress of the European Society for Medical Oncology (ESMO) October 8-12, 2010, Milan, Italy (Conference Report) (Conference Notes) 35th Congress of the European Society for Medical Oncology (ESMO) October 8-12, 2010, Milan, Italy (Conference Report) (Conference Notes)

35th Congress of the European Society for Medical Oncology (ESMO) October 8-12, 2010, Milan, Italy (Conference Report) (Conference Notes‪)‬

Advances in Oncology 2010, Dec, 5, 4

Advances in Oncology
    • $5.99
    • $5.99

Publisher Description

Introduction This year's meeting revealed innovative progress from clinical trials, new drugs and therapy developments. Scientific advancement of genetic and proteomic profiling was highlighted, as well as the identification of microRNAs for diagnosis. The focus of this meeting was on the use of molecular-targeted therapies with acceptable safety profiles to treat different cancers. The quality of the scientific programme at this congress was extremely high, and a number of studies will be remembered because of their implications for oncology practice.

GENRE
Health, Mind & Body
RELEASED
2010
December 1
LANGUAGE
EN
English
LENGTH
11
Pages
PUBLISHER
Mediscript Ltd.
SELLER
The Gale Group, Inc., a Delaware corporation and an affiliate of Cengage Learning, Inc.
SIZE
215.1
KB

More Books by Advances in Oncology

Metastatic Colorectal Cancer: Are We Talking About Curability?(Gastrointestinal Cancers) Metastatic Colorectal Cancer: Are We Talking About Curability?(Gastrointestinal Cancers)
Metastatic Colorectal Cancer: Are We Talking About Curability?(Gastrointestinal Cancers)
2010
Sutent Satellite Symposium: Held Parallel to the 15th Annual Scientific Meeting of Alexandria Clinical Oncology Department (ACOD) Alexandria, Egypt, 14-16 April 2010: a Report from the Symposium (Conference Report: Renal Cell Carcinoma) (Report) Sutent Satellite Symposium: Held Parallel to the 15th Annual Scientific Meeting of Alexandria Clinical Oncology Department (ACOD) Alexandria, Egypt, 14-16 April 2010: a Report from the Symposium (Conference Report: Renal Cell Carcinoma) (Report)
Sutent Satellite Symposium: Held Parallel to the 15th Annual Scientific Meeting of Alexandria Clinical Oncology Department (ACOD) Alexandria, Egypt, 14-16 April 2010: a Report from the Symposium (Conference Report: Renal Cell Carcinoma) (Report)
2010
The Future Is Brite (Feature Article) (Clinical Report) The Future Is Brite (Feature Article) (Clinical Report)
The Future Is Brite (Feature Article) (Clinical Report)
2009
Aromatase Inhibitors and Evolution of the Lipid Profile (Clinical Report) Aromatase Inhibitors and Evolution of the Lipid Profile (Clinical Report)
Aromatase Inhibitors and Evolution of the Lipid Profile (Clinical Report)
2009
Neoadjuvant and Adjuvant Therapy for Renal Cell Carcinoma: A New Treatment Paradigm for Locally Advanced and Metastatic Disease in the Era of Targeted Therapy (Feature Article) (Clinical Report) Neoadjuvant and Adjuvant Therapy for Renal Cell Carcinoma: A New Treatment Paradigm for Locally Advanced and Metastatic Disease in the Era of Targeted Therapy (Feature Article) (Clinical Report)
Neoadjuvant and Adjuvant Therapy for Renal Cell Carcinoma: A New Treatment Paradigm for Locally Advanced and Metastatic Disease in the Era of Targeted Therapy (Feature Article) (Clinical Report)
2010
91-Month Analysis of the Inter-Group Exemestane Study (IES): Exemestane After Initial Therapy with Tamoxifen in Postmenopausal Women with Early Breast Cancer (Breast Cancer) (Case Study) 91-Month Analysis of the Inter-Group Exemestane Study (IES): Exemestane After Initial Therapy with Tamoxifen in Postmenopausal Women with Early Breast Cancer (Breast Cancer) (Case Study)
91-Month Analysis of the Inter-Group Exemestane Study (IES): Exemestane After Initial Therapy with Tamoxifen in Postmenopausal Women with Early Breast Cancer (Breast Cancer) (Case Study)
2010